196 related articles for article (PubMed ID: 8704189)
21. Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology Group.
Paietta E; Andersen J; Racevskis J; Ashigbi M; Cassileth P; Wiernik PH
Blood Rev; 1995 Mar; 9(1):47-52. PubMed ID: 7540903
[TBL] [Abstract][Full Text] [Related]
22. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M
Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811
[TBL] [Abstract][Full Text] [Related]
23. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia.
van der Kolk DM; de Vries EG; Noordhoek L; van den Berg E; van der Pol MA; Müller M; Vellenga E
Leukemia; 2001 Oct; 15(10):1544-53. PubMed ID: 11587212
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
[TBL] [Abstract][Full Text] [Related]
26. Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
Elgie AW; Sargent JM; Williamson CJ; Lewandowicz GM; Taylor CG
Adv Exp Med Biol; 1999; 457():29-33. PubMed ID: 10500777
[TBL] [Abstract][Full Text] [Related]
27. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
28. Discordance of P-glycoprotein expression and function in acute leukemia.
De Moerloose B; Dhooge C; Philippé J
Adv Exp Med Biol; 1999; 457():107-18. PubMed ID: 10500786
[TBL] [Abstract][Full Text] [Related]
29. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
30. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
[TBL] [Abstract][Full Text] [Related]
31. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
Tijerina M; Fowers KD; Kopecková P; Kopecek J
Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
33. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
34. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
35. Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cells.
Taylor BJ; Olson DP; Ivy SP
Leuk Res; 2001 Dec; 25(12):1127-35. PubMed ID: 11684287
[TBL] [Abstract][Full Text] [Related]
36. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
[TBL] [Abstract][Full Text] [Related]
37. New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.
Takeshita A; Shinjo K; Ohnishi K; Ohno R
Jpn J Cancer Res; 1995 Jun; 86(6):607-15. PubMed ID: 7622426
[TBL] [Abstract][Full Text] [Related]
38. Establishment of multidrug-resistance cell line C(6)/adr and reversal of drug-resistance.
Liu F; Wang C; Zhang Q; Li J; Zhang Y
Chin Med J (Engl); 2002 Feb; 115(2):238-41. PubMed ID: 11940340
[TBL] [Abstract][Full Text] [Related]
39. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
